Primary Mediastinal Large B-Cell Lymphoma: A Comparative Study With Nodular Sclerosis—Type Hodgkin’s Disease

No abstract is available for this paper.

• Publication year

  2001

• Venue

  International journal of hematology

• Publication date

  2001-08-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02982002PMID 11594519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mediastinal large B-cell lymphoma vs classic Hodgkin lymphoma.

  1999cited by this paper
• Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.

  1999cited by this paper
• Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases.

  1999influential reference
• The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

  1999cited by this paper
• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  1999cited by this paper
• CD30 expression is common in mediastinal large B-cell lymphoma.

  1999cited by this paper
• Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.

  1998cited by this paper
• MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis.

  1998cited by this paper
• Classical Hodgkin's disease. Clinical impact of the immunophenotype.

  1997cited by this paper
• Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.

  1997cited by this paper
• [Autologous peripheral blood stem cell transplantation for CHOP-resistant mediastinal diffuse large B-cell lymphoma].

  1997cited by this paper
• Mediastinal large B‐cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third‐generation regimens

  1995cited by this paper
• Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non‐Hodgkin's lymphoma

  1994cited by this paper
• [A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas].

  1994cited by this paper
• [Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin].

  1994cited by this paper
• Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients.

  1993cited by this paper
• Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.

  1993cited by this paper
• Primary large cell lymphoma of the mediastinum.

  1993cited by this paper
• Primary large-cell lymphoma of the mediastinum.

  1993cited by this paper
• A study of 15 cases of primary mediastinal lymphoma of B‐cell type

  1992cited by this paper
• Primary anterior mediastinal b‐cell lymphoma. A clinicopathologic and immunohistochemical study of 16 cases

  1991cited by this paper
• Mediastinal large cell lymphoma: An uncommon subset of adult lymphoma curable with combined modality therapy

  1988cited by this paper
• Thymic medullary cells expressing B lymphocyte antigens.

  1988cited by this paper
• The human thymus contains a novel population of B lymphocytes.

  1987cited by this paper
• MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma.

  1985cited by this paper
• Diffuse large cell and undifferentiated lymphomas with promiment mediastinal involvement. A poor prognoctic subset of patients with non‐Hodgkin's lymphoma

  1982cited by this paper

• Prognostic value of pre-therapy C-reactive protein level in diffuse large B-cell lymphoma: a meta-analysis

  2018cites this paper
• Primary mediastinal large B-cell lymphoma.

  2015cites this paper
• Genomic Alterations in Hodgkin’s Lymphoma

  2006cites this paper
• Primary Mediastinal Large B-Cell Lymphoma: A Single-Institution Clinical Study in Japan

  2004cites this paper